Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
clinical trials
deals
5
×
fda
5
×
life sciences
national blog main
new york blog main
5
×
biotech
boston blog main
boston top stories
national top stories
new york top stories
san diego blog main
san diego top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
investing
national
raleigh-durham blog main
raleigh-durham top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
alnylam pharmaceuticals
cancer
cancer immunotherapy
drugs
johnson & johnson
nonalcoholic steatohepatitis
regeneron pharmaceuticals
rna interference
What
drug
5
×
fda
roundup
bio
cash
company
disease
medicines
news
acquire
agreed
ahead
ambien
american
annual
approved
aren’t
asco
attendees
attention
bacteria
billion
biopharma
biotech
brings
business
camp’s
cancer
chicago
cholesterol
city
clinical
combinations
community’s
companies
compound
days
deal
developers
digital
Language
unset
Current search:
fda
×
drug
×
deals
×
" new york blog main "
×
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Qpex Biopharma Launches with $33M to Tackle Drug-Resistant Infections
@xconomy.com
5 years ago
Bio Roundup: Medicare Drug Prices, FDA Moves, Gene Therapy News & More
@xconomy.com
5 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More
